Loading
A phase 3 trial in colorectal cancer, run by Zhejiang Cancer Hospital, now recruiting.
ctDNA-guided Selection of Adjuvant Chemotherapy Regimens for Elderly Colon Cancer Patients After Surgery: A Single-center, Randomized, Controlled Study is a phase 3, randomised interventional study registered as NCT06609551 by Zhejiang Cancer Hospital, with a registry enrolment figure of 312 participants, started 2024-07-03 and due to reach its primary completion in 2029-12-31. Interventions recorded: 6-month adjuvant chemotherapy with 5-FU monotherapy; XELOX intensive treatment group. Conditions listed: Colon Cancer; Colon Cancer (Stage II &Amp;Amp;Amp; III). Primary outcome: 2-year DFS (Disease-Free Survival). Colorectal eligibility wording from the registry: "Patients with histopathologically confirmed stage II high-risk or stage III colon cancer;". Sites: China. No results are recorded here; the registry entry is the source.
Shares MRD / molecular residual disease testing, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares MRD / molecular residual disease testing, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares MRD / molecular residual disease testing, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares MRD / molecular residual disease testing, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares MRD / molecular residual disease testing, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares MRD / molecular residual disease testing, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares MRD / molecular residual disease testing, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.